drugset / Trial / NCT04952480

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

NCT04952480 ↗

Phase 2 Recruiting 31 enrolled AHS Cancer Control Alberta
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out what effects of using adaptive radiotherapy to deliver chest radiation has on the ability to control lung cancer and side effects.

Timeline

Start
2022-06-13
Primary completion
2025-11-01
Completion
2025-11-01

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified — —
Background Etoposide Small molecule — —